Strategic Management to Improve CRT Using Multi-Site Pacing Post Approval Study (Reference # C1918) (SMARTMSP)
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT03257436|
Recruitment Status : Completed
First Posted : August 22, 2017
Last Update Posted : January 14, 2021
|Condition or disease||Intervention/treatment||Phase|
|Left Ventricular Dysfunction||Device: CRT-D||Not Applicable|
|Study Type :||Interventional (Clinical Trial)|
|Actual Enrollment :||586 participants|
|Intervention Model:||Single Group Assignment|
|Masking:||None (Open Label)|
|Official Title:||Strategic Management to Improve CRT Using Multi-Site Pacing Post Approval Study (Reference # C1918)|
|Actual Study Start Date :||December 13, 2017|
|Actual Primary Completion Date :||November 19, 2020|
|Actual Study Completion Date :||November 19, 2020|
General population who receive a Boston Scientific Resonate family of CRT-D device in accordance with its labeled indication for use.
Left Ventricular MultiSite Pacing
- LV MSP feature [ Time Frame: Between 6 month visit and the 12 month visit in non-responders with LV MSP on for any duration. ]Related complication-free rate.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03257436
|Principal Investigator:||Saba Samir||University of Pittsburgh Medical Center|